iSpecimen Inc.ISPCNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -4.17% | -42.70% | -53.82% | -75.10% | -96.00% |
| Gross Profit Growth | -20.03% | -86.81% | -68.97% | -81.31% | -108.85% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +51.60% | +57.73% | +55.68% | +340.34% | +749.84% |
| Weighted Average Shares Diluted Growth | +51.60% | +56.64% | +55.68% | +340.34% | +749.84% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -1094.57% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -16.05% | -50.88% | -75.92% | -86.91% | -95.40% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -30.87% | -40.89% | -45.31% | -49.30% | -20.12% |
| Book Value per Share Growth | -75.52% | -78.45% | -84.27% | -97.68% | -92.33% |
| Debt Growth | +407.11% | +59.07% | +91.54% | +888.28% | -76.32% |
| R&D Expense Growth | -100.00% | -1.67% | -40.20% | -41.19% | +0.00% |
| SG&A Expenses Growth | -23.78% | +48.52% | -60.08% | -43.57% | +31.53% |